Literature DB >> 2983887

Amplification of the c-myc oncogene in a subpopulation of human small cell lung cancer.

K Saksela, J Bergh, V P Lehto, K Nilsson, K Alitalo.   

Abstract

We have examined a panel of human lung cancer cell lines for amplification and expression of the c-myc, N-myc, and c-myb oncogenes. The cell lines analyzed represent various histopathological types of lung cancer: small cell carcinoma with neuroendocrine properties; squamous cell carcinoma with epithelial markers; and large cell carcinoma with a mixed neuroendocrine-epithelial phenotype. Two of six cell lines, both of which were small cell carcinomas, showed about a 20-fold amplification of the c-myc oncogene. In both cell lines, the amplification is accompanied by an enhanced expression of c-myc. The N-myc or c-myb genes were not amplified in any of the cell lines, nor were they expressed in detectable amounts. The results confirm and extend earlier findings on c-myc amplification in small cell lung cancer.

Entities:  

Mesh:

Year:  1985        PMID: 2983887

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  17 in total

1.  Assignment of the gene encoding the catalytic subunit C beta of cAMP-dependent protein kinase to the p36 band on chromosome 1.

Authors:  J Simard; D Bérubé; M Sandberg; K H Grzeschik; R Gagné; V Hansson; T Jahnsen
Journal:  Hum Genet       Date:  1992-03       Impact factor: 4.132

Review 2.  Studying lung cancer in the laboratory: 3--Use of cell lines to investigate the biology of lung cancer.

Authors:  R J Fergusson; J F Smyth
Journal:  Thorax       Date:  1987-12       Impact factor: 9.139

3.  myc family oncogene amplification in tumor cell lines established from small cell lung cancer patients and its relationship to clinical status and course.

Authors:  B E Johnson; D C Ihde; R W Makuch; A F Gazdar; D N Carney; H Oie; E Russell; M M Nau; J D Minna
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

4.  TNM stage, immunohistology, syntactic structure analysis and survival in patients with small cell anaplastic carcinoma of the lung.

Authors:  K Kayser; M Fitzer; H Bülzebruck; K Bosslet; P Drings
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

5.  Different pattern of expression of cellular oncogenes in human non-small-cell lung cancer cell lines.

Authors:  P E Kiefer; B Wegmann; M Bacher; C Erbil; H Heidtmann; K Havemann
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

6.  The gene encoding the human preproacrosin (ACR) maps to the q13-qter region on chromosome 22.

Authors:  I M Adham; K H Grzeschik; A H Geurts van Kessel; W Engel
Journal:  Hum Genet       Date:  1989-12       Impact factor: 4.132

7.  Regulation of platelet-derived growth factor gene expression by transforming growth factor beta and phorbol ester in human leukemia cell lines.

Authors:  T P Mäkelä; R Alitalo; Y Paulsson; B Westermark; C H Heldin; K Alitalo
Journal:  Mol Cell Biol       Date:  1987-10       Impact factor: 4.272

8.  MYC amplification is associated with poor survival in small cell lung cancer: a chromogenic in situ hybridization study.

Authors:  Rita de Cássia S Alves; Rosalva Thereza Meurer; Adriana Vial Roehe
Journal:  J Cancer Res Clin Oncol       Date:  2014-07-11       Impact factor: 4.553

9.  Two distinct cell lines derived from a human osteosarcoma.

Authors:  A Kawai; T Ozaki; S Ikeda; T Oda; M Miyazaki; J Sato; K Taketa; H Inoue
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

10.  Malignant epithelial cells in primary human lung carcinomas coexpress in vivo platelet-derived growth factor (PDGF) and PDGF receptor mRNAs and their protein products.

Authors:  H N Antoniades; T Galanopoulos; J Neville-Golden; C J O'Hara
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.